Newsletter Tool

To view this email as a web page, click here

Today's Rundown

Pfizer, AstraZeneca COVID vaccines probed in Europe after reports of heart inflammation, rare nerve disorder
Black doctors read COVID tweets in fun, fact-filled campaign to raise vaccination awareness
Insurers boost 2021 guidance in Q1 even as pandemic's impact remains murky
COVID-19 tracker: Sinopharm vaccine wins WHO support; EU finalizing supply deal for 1.8B Pfizer doses
Even with the pandemic in retreat, Amgen will let most employees keep working from home
UPDATED Coronavirus tracker: CMS increases payment for monoclonal antibody treatment

Featured Story

Pfizer, AstraZeneca COVID vaccines probed in Europe after reports of heart inflammation, rare nerve disorder

By Noah Higgins-Dunn

The European Medicines Agency’s safety committee said on Friday that it's evaluating an assortment of potential side effects following inoculation with most leading COVID-19 vaccines, including heart inflammation, facial swelling and a rare nerve-degenerating disorder.

Black doctors read COVID tweets in fun, fact-filled campaign to raise vaccination awareness

By Beth Snyder Bulik

The new “Black Doctors Read COVID Tweets” social media campaign looks to raise awareness and education in the Black community about vaccines. It's the kind of work pharma can learn from as it works to build trust with a still-skeptical public.

Insurers boost 2021 guidance in Q1 even as pandemic's impact remains murky

By Paige Minemyer

Major national health insurers largely increased their financial outlook for the year in Q1, despite warning that plenty of uncertainty remains around the impacts of COVID-19.

COVID-19 tracker: Sinopharm vaccine wins WHO support; EU finalizing supply deal for 1.8B Pfizer doses

By Noah Higgins-Dunn,Kevin Dunleavy,Fraiser Kansteiner

The World Health Organization issued an emergency authorization for the COVID-19 vaccine from China’s state-owned drugmaker Sinopharm. The EU is reportedly finalizing a massive supply deal with Pfizer for 1.8 billion doses of its BioNTech-partnered vaccine. Senior CDC official Nancy Messonnier announced her resignation. And more headlines.

Even with the pandemic in retreat, Amgen will let most employees keep working from home

By Kevin Dunleavy

Even with the coronavirus pandemic subsiding and offices opening up, Amgen will continue to allow employees to work from home. The measure will continue for the foreseeable future.

UPDATED Coronavirus tracker: CMS increases payment for monoclonal antibody treatment

By Healthcare Staff

Follow along with the latest COVID-19 news straight from the Fierce Healthcare team.

COVID-19 Tracker